41 results about "Jaundice" patented technology

The invention relates to the technical field of pediatric medical treatment, and discloses a pediatric neonatal jaundice clinical phototherapy management system, which integrates illumination data in an equipment lamp box through a data integration module, extracts the illumination data acquired by the data integration module through a fusion analysis module, and fuses the operation duration of a lamp tube to obtain a phototherapy result. An equipment health state basic model is established, the current equipment health state is predicted through an equipment prediction module on the basis of the established health state basic model, a prediction result is fed back, a patient information system is connected through a personality support module, and basic physiotherapy data of a patient is acquired. And outputting recommended illumination intensity and recommended treatment time based on the basic physiotherapy data, and monitoring a plurality of pieces of monitoring information and feedback output results through a remote monitoring module. The system accurately solves the core problems of dynamic fluctuation of phototherapy intensity, calibration lag and lack of personalized adaptation, and finally achieves dual guarantee of phototherapy effect and safety.

The invention relates to a chemiluminescence kit for detecting pepsinogen II. The kit comprises an enzyme marker, a luminescent substrate solution and an anti-interference buffer system, the anti-interference buffer system comprises a nonionic surfactant, animal-derived IgG (immunoglobulin G), an antioxidant and catalase; the chemiluminescence kit also comprises a PG II calibration product and a PG II quality control product. The core active component of the enzyme marker is beta-galactosidase. The enzyme marker further comprises an anti-PG II monoclonal antibody marked by beta-galactosidase, bovine serum albumin, trehalose, cane sugar, MgCl2. 6H2O, sodium chloride, Proclin300 and a phosphate buffer solution. According to the kit, a brand-new anti-interference buffer system is introduced on the basis of a spatial proximity chemiluminescence analysis method, so that the resistance to clinically common interferents (such as hemolysis, lipemia, jaundice and heterotropism antibodies) is remarkably improved, and the detection result is more accurate and reliable.

The application discloses a sample information identification method, a computer readable storage medium and an identification device. The sample information identification method comprises the following steps: transporting a sample tube to a first identification area by controlling a transportation guide rail, acquiring sample tube information by a sample tube information reading mechanism; controlling an identification mechanism to capture a first image information of the sample tube; analyzing the first image information to acquire first identification information; comparing the first identification information with the sample tube information; if the first identification information matches the sample tube information, adjusting the position of a mechanical hand according to the first identification information to clamp the sample tube and move the sample tube to a second identification area; and acquiring sample information of the sample tube located in the second identification area. According to the sample information, whether the blood sample in the sample tube has hemolysis, jaundice and chyle phenomena and the severity information of the disease can be obtained, so that an abnormal sample with a relatively large influence on detection error can be identified.

The invention discloses an intelligent medical system based on a portable shared jaundice instrument and a use method, and the system comprises a patient end which is used for equipment leasing, payment and measurement display; the portable jaundice instrument terminal is used for acquiring data and wirelessly transmitting the data; the cloud service platform analyzes the data based on an AI algorithm and generates diagnosis suggestions; the medical care terminal is used for auditing the data and pushing a result; the rental cabinet terminal manages access of equipment; and the data collaboration module is used for realizing data synchronization between each terminal and the hospital server. According to the invention, through deep integration of a shared leasing mode and AI cloud auxiliary diagnosis, three breakthroughs of jaundice detection are realized: professional detection is extended to families through Internet of Things hardware and a cloud auxiliary system; a cloud dynamic calibration algorithm effectively assists household measurement operation and eliminates regional skin color interference, and the deviation between the system and manual measurement is reduced; a'user-cloud-doctor 'three-level closed-loop system is constructed, the overall screening efficiency is improved, and jaundice full-link management and hierarchical diagnosis and treatment are supported.

The invention belongs to the technical field of pediatric medicine, and particularly relates to a jaundice irradiation device for pediatric nursing and a use method. Comprising a base, a bearing shell is fixedly connected to the base, a shielding shell is fixedly connected to the bearing shell, a covering shell is hinged to the shielding shell, an irradiation lamp is installed on the covering shell, a supporting shaft is arranged on the bearing shell, a supporting frame is fixedly connected to the middle of the supporting shaft, and first push rods which are symmetrically distributed are hinged to the supporting frame; a mounting plate is hinged to the telescopic end of the first push rod, chain plates distributed in an array mode are hinged to the mounting plate, and a sliding rod is arranged on the side, away from the corresponding mounting plate, of each chain plate. The baby is pushed through bending of all the chain plates on the same side, so that the baby rotates slowly, the turning operation of the baby is assisted, the operation difficulty of a doctor is reduced, the turning operation is smoother, and the crying probability of the baby is reduced.

This item is notebook paper used for recording neonatal jaundice and physiological weight loss.

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating hepatobiliary diseases, the traditional Chinese medicine composition has the effects of soothing liver-gallbladder, clearing away heat and toxic materials, promoting qi circulation, dispersing blood stasis, regulating qi, activating blood, benefiting gallbladder and removing urinary calculus, and is clinically used for treating cholelithiasis, cholecystitis, jaundice, hepatitis and other diseases. The preparation has the advantages of good curative effect, small side effect, low price, convenience in taking and the like, and exerts the unique advantage of the traditional Chinese medicine in treating hepatobiliary diseases.

The application relates to the field of biological medicine, and discloses application of folic acid in prevention, diagnosis and treatment of genetic, infectious or allergic diseases. The application finds that the folic acid can achieve the prevention and treatment effects on the genetic, infectious or allergic diseases by improving inflammation, regulating iron ion metabolism, correcting intestinal flora disorder, reducing liver / intestinal tissue damage, inhibiting expression of inflammatory factors and promoting expression of Nox2. Meanwhile, the application provides application of one or more of the folic acid, S100a8, S100a9, Nox2 and IFN-gamma as a diagnostic or auxiliary diagnostic marker of biliary atresia. Meanwhile, the application provides the folic acid or a derivative thereof, which is prepared into food, a nutritional preparation or a medicine and applied to children or adults, so as to achieve the purposes of preventing and treating biliary atresia, cholangitis, jaundice, infectious diseases, intestinal diseases and diseases caused by abnormal folic acid metabolism.

The application belongs to the technical field of biological detection, and particularly relates to the use of apolipoprotein A-I in the preparation of a diagnostic reagent or system for predicting the risk of severe acute hepatitis E. The application first discloses and verifies the significant correlation between the serum apolipoprotein A-I (apoA-I) level and the adverse clinical outcomes (including severe jaundice, liver failure and death) of patients with acute hepatitis E, and establishes the risk interpretation threshold (0.675 g / L and 0.435 g / L) with clinical practical value. The application can objectively and early identify high-risk patients, and provides a powerful auxiliary tool for clinical stratified management and resource optimization.

The invention relates to the technical field of medical instruments, in particular to a control method and system of a jaundice treatment device. The method comprises the following steps: acquiring evaluation data of a user, wherein the evaluation data comprises spectral reflectivity; inputting the evaluation data into a preset prediction model to obtain a bilirubin concentration risk score and a bilirubin concentration prediction value at a next prediction moment; in response to the bilirubin concentration risk score being greater than a risk threshold, determining a candidate interval corresponding to a phototherapy parameter based on the bilirubin concentration risk score, the phototherapy parameter including a light source wavelength; inputting the predicted value of the bilirubin concentration into an MPC optimizer, so that the MPC optimizer selects an optimal phototherapy parameter from the candidate interval; and outputting the optimal phototherapy parameter, so that the jaundice treatment device outputs a corresponding treatment light source. According to the method, the condition of excessive treatment can be avoided.

The invention relates to the technical field of probiotics, and discloses a probiotic preparation for improving abnormal bile diseases of newborns. According to the probiotic preparation provided by the invention, lactobacillus fermentum CECT5716, bifidobacterium breve M-16V and bifidobacterium longum subsp. Longum BB536 in the list of strains for infants are selected as a product formula, and the probiotic preparation can be used for effectively improving abnormal bile diseases of newborns, including jaundice, hyperbilirubinemia and cholestasis, and can be used for preventing and treating the abnormal bile diseases of the newborns, such as jaundice, hyperbilirubinemia and cholestasis. The problems that in the prior art, safety is insufficient, pertinence is insufficient, and clinical requirements of complex illness conditions cannot be met are effectively solved.

The invention relates to an external preparation for treating skin itch of a patient with jaundice and a preparation method of the external preparation, and relates to the technical field of traditional Chinese medicine. The traditional Chinese medicine extract comprises the following raw materials in parts by weight: 25-35 parts of humulus lupulus, 10-20 parts of chionanthus retusus leaves and 10-20 parts of rhizoma tupistrae chinensis. A proper amount of humulus lupulus, chionanthus retusus leaves and rhizoma tupistrae chinensis are matched and used as functional components, and the humulus lupulus, the chionanthus retusus leaves and the rhizoma tupistrae Meanwhile, by combining a gradient decompression reflux extraction mode, effective components are efficiently extracted and fully reserved, so that the improvement effect of the obtained traditional Chinese medicine composition on the skin itch symptom of the jaundice patient is remarkably improved, the treatment effect is superior to that of an existing conventional medicine, a new means is provided for treating the skin itch disease of the jaundice patient, and the application prospect is wide.

A jaundice diagnosis and treatment system includes a control circuit, a bilirubin measurement assembly, a risk evaluation circuit and a display assembly, wherein the bilirubin measurement assembly is communicatively connected to the control circuit, and is used for measuring a bilirubin concentration of a newborn baby and transmitting the measured bilirubin concentration to the control circuit, so that the control circuit generates measurement data according to the measured bilirubin concentration; the risk evaluation circuit is communicatively connected to the control circuit, and is used for acquiring the measurement data from the control circuit and evaluating a pathologic jaundice risk level according to the measurement data; and the display assembly is connected to the control circuit, and is used for displaying the measurement data and / or the pathologic jaundice risk level under the control of the control circuit.

The application discloses a traditional Chinese medicine granule for treating jaundice and a preparation method and application thereof. The traditional Chinese medicine granule is prepared from the following traditional Chinese medicine raw materials in parts by mass: radix rehmanniae 14-16 parts, radix et rhizoma rhei 6.5-8.5 parts, fructus aurantii immaturus 6.5-8.5 parts, radix pini 6.5-8.5 parts, herba taraxaci 14-16 parts. The traditional Chinese medicine granule is used for treating jaundice, acute and chronic hepatitis mainly manifested as jaundice (yellowish urine), and the clinical manifestations are yellowish urine, abdominal distension or abdominal distension and pain, poor appetite, yellow urine, dysuria, constipation or diarrhea, red or dark red tongue, yellow tongue fur, and slow and thin pulse. The traditional Chinese medicine granule is determined through years of clinical application, and the results show that the traditional Chinese medicine granule can be used for treating jaundice caused by various acute and chronic hepatitis, and the curative effect is very good, the effect is fast, the curative effect is accurate, the medicine is less, and the cost is low.

This invention belongs to the field of traditional Chinese medicine oral decoction preparation technology. Specifically, it relates to a method for preparing a stable and safe decoction of traditional Chinese medicine composition for hepatitis, jaundice virus, cirrhosis, and ascites. The decoction is prepared by decocting the following eleven traditional Chinese medicine components: 30g of raw Lysimachia christinae, 30g of Plantago asiatica, 30g of Poria cocos peel, 30g of Dioscorea opposita, 26g of Areca catechu peel, 16g of Salvia miltiorrhiza, 16g of Bupleurum chinense, 16g of Alisma plantago-aquatica, 16g of Astragalus membranaceus, 13g of Lycopus lucidus, and 10g of processed pangolin scales. When decocting, pour the mixture into a sterilized and cleaned porcelain medicine pot, add cold water and soak for 30 minutes. Bring to a boil over high heat, then simmer over low heat for 20 minutes. Turn off the heat and let it cool slightly before drinking. This is the medicine product. By combining classical traditional methods with modern decoction technology, the decoction of these eleven traditional Chinese medicines yields a traditional Chinese medicine preparation with significant effects and convenient administration. This formula features comprehensive regulation and enhancement. It selects herbs such as Lysimachia christinae, Plantago asiatica, Poria cocos, and Salvia miltiorrhiza, which have antibacterial, drainage, dampness-removing, anti-inflammatory, and blood-stasis-removing components for liver ascites. The combination of eleven Chinese herbs has anti-inflammatory, detoxifying, and dampness-removing effects, which are beneficial for treating liver ascites lesions, removing hepatitis, jaundice, tuberculosis, damp-heat accumulation, inflammation-induced ascites, enhancing immunity, and healing effects.

This invention discloses a pediatric jaundice treatment device and method for pediatric clinicians, relating to the field of medical device technology. The invention includes a base with an outer shell fixedly connected to its top. An opening and closing plate is connected to the inner wall of the outer shell via hinges. An inner light-transmitting shell is located on the top of the base, slightly smaller than the outer shell, and has a gap in between. This invention achieves dynamic tracking of the infant's torso by setting a U-shaped block and a rotating alignment mechanism. When the infant's sleeping position changes from supine to lateral, the pressure-sensing mattress detects the change in torso position in real time. A second controller transmits this signal to a first controller, driving a micro-motor to rotate a second lead screw, causing the U-shaped block to rotate to the corresponding angle. Simultaneously, the first motor drives the first lead screw to lower the mounting shell and rotating block to a position facing the side of the torso, ensuring that the light group is always aligned with the core area of ​​bilirubin accumulation.

The present application belongs to the technical field of medical apparatus and specifically discloses a new-born jaundice treatment device, which comprises a heat preservation box body, a box cover arranged above the heat preservation box body, and a rotating plate symmetrically and interval arranged inside the heat preservation box body, the rotating plate is rotationally arranged at the center of the heat preservation box body, a receiving groove is rotationally arranged between the middle portions of the two rotating plates, lamp plates are symmetrically and slidingly arranged between the two ends of the two rotating plates, lamp distance adjusting mechanisms are symmetrically arranged on the opposite sides of the two rotating plates, an installation rod connecting the two rotating plates is arranged on the outside of one of the lamp plates, and an electric telescopic rod is arranged between the installation rod and the adjacent lamp plate. The present application independently or synchronously controls the coaxial rotation of the rotating plate and the receiving groove through two driving mechanisms, so that the rotating plate drives the lamp plate to revolve around the receiving groove to realize all-around irradiation, the receiving groove can be synchronously tilted with the lamp plate, the light distance is kept constant when preventing choking and feeding milk, the lamp distance adjusting mechanism can realize synchronous distance adjustment of the two lamp plates, and the efficiency and safety of treatment are greatly improved.

The invention belongs to the technical field of biological medicines, and particularly relates to application of parinumod in preparation of a medicine for treating biliary atresia. The invention discovers the treatment application of the S100A8 / A9 inhibitor in biliary atresia for the first time. The method comprises the following steps: inducing the formation of BA by intraperitoneal injection of RRV within 24 hours after a BALB / c newborn mouse is born, and after the RRV is injected from the intraperitoneal cavity, from the second day, injecting an S100A8 / A9 inhibitor Paquinimod (dosage: 50 mg / kg) into the intraperitoneal cavity of the mouse once every other day until the twelfth day. It can be observed that the survival time of the BA mouse treated by Paquinimod is prolonged, the jaundice symptom is relieved, the liver function index is obviously improved, and the infiltration number of inflammatory cells around the hepatic bile duct is obviously reduced. The invention provides a new potential target and a treatment strategy for treatment of BA.

The invention provides a medicine bag for conditioning jaundice and a preparation method of the medicine bag. The medicine bag comprises the following medicinal material components in parts by weight: 1-5 parts of solanum lyratum, 1-5 parts of wild chrysanthemum stems, 1-4 parts of penthorum chinense pursh, 1-5 parts of honeysuckle stems, 1-4 parts of corn stigma, 1-4 parts of silkworm excrement, 1-5 parts of philippine violet herb, 1-5 parts of barberry, 2-6 parts of lygodium japonicum, 1-4 parts of oriental wormwood, 1-4 parts of lysimachia christinae hance and 1-4 parts of plantain herb. According to the scheme, intervention is performed from a bilirubin metabolism source and biliary secretion and excretion links. The silkworm excrement, the lygodium japonicum, the philippine violet herb and the penthorum chinense pursh in the formula cooperate to promote biliary secretion and accelerate discharge of bilirubin through intestinal tracts; meanwhile, herba artemisiae scopariae, radix et rhizoma rhei, solanum lyratum and other medicinal materials clear away liver and gallbladder damp-heat and improve the liver microenvironment; the corn stigma, the plantain herb and the like assist uncombined bilirubin to be excreted from the kidney through the diuretic effect, a multi-way synergistic mechanism of promoting secretion, clearing damp and heat and promoting urination and defecation is formed, three-dimensional conditioning of jaundice is achieved, and the curative effect is remarkable.

The invention relates to the technical field of Mongolian medicines, discloses a Mongolian medicine composition for treating a liver-heat-type liver disease, and aims to solve the problems that when an existing Mongolian medicine scheme is used for treating complex diseases with liver parenchyma injury and liver and gall dysfunction, the synergism of liver heat clearing and liver and gall dysfunction is insufficient, and overall intervention is difficult. The Mongolian medicine composition is prepared from twenty-one medicinal materials including bunge corydalis herb, coptis chinensis, fructus gardeniae, bistort rhizome, bear gall powder, fructus choerospondiatis, radix aucklandiae, flos caryophyllata, amomum tsao-ko, myristica fragrans and the like. The traditional Chinese medicine composition is prepared by adopting a staged extraction process, comprehensively plays the effects of protecting the liver, lowering transaminase, benefiting the gallbladder, relieving jaundice and improving the gastrointestinal function, and shows better comprehensive treatment effect and safety on drug-induced, alcoholic and non-alcoholic fatty liver injuries.

The invention relates to the technical field of preparation of bath foam, and particularly discloses bath foam capable of relieving jaundice symptoms and a preparation method of the bath foam. The bath foam capable of relieving jaundice symptoms is prepared from 325 to 820 parts of water, 72 to 183 parts of glycerinum, 8 to 12 parts of honeysuckle extract, 8 to 12 parts of amur corktree bark extract, 6 to 10 parts of artemisia capillaris extract, 3 to 8 parts of selfheal extract, 3 to 8 parts of agastache rugosus extract, 3 to 8 parts of oldenlandia diffusa extract, 0.5 to 1.5 parts of orange peel oil, 6 to 10 parts of gardenia fruit extract and 3 to 8 parts of radix gentianae extract. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 0.5-1.5 parts of ginseng leaf extract, 0.5-1.5 parts of gleditsia sinensis seed extract, 0.5-1.5 parts of eupatorium extract, 0.5-1.5 parts of lysimachia christinae hance extract and 2.15-5.5 parts of The bath foam disclosed by the invention has the functions of clearing liver and benefiting gallbladder, clearing heat and eliminating dampness, soothing liver and regulating qi, lowering liver fire, removing dysphoria and relieving jaundice, and is suitable for relieving symptoms such as unsmooth biliary secretion, poor liver and gallbladder functions, stagnation of liver qi, hyperactivity of liver fire and jaundice of infants.

The present invention relates to a computer-based jaundice monitoring system that uses image processing technology to monitor and detect jaundice in a patient. The system includes a camera for capturing patient images, a computing device for image processing and analysis, a local communication network for interconnecting system components, and a light panel integrated with the camera for providing phototherapy. The computing device identifies a patient's skin site, analyzes the dominant color within the skin site, detects yellow pigmentation indicative of jaundice, and generates a notification accordingly.

1. Name of the product in this design: Jaundice Treatment Device. 2. Purpose of this design: For the treatment of jaundice in infants and young children. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1.

The present application provides a kind of traditional Chinese medicine composition for improving damp-heat type skin yellow turbidity, it is composed of the following weight parts of raw materials: 5-8 parts of wine-fried gentiana scabra, 12-18 parts of wine-fried scrophularia, 12-18 parts of wine-fried gardenia, 12-18 parts of alisma, 12-18 parts of akebia, 12-18 parts of psyllium, 12-18 parts of wine-fried angelica, 18-25 parts of raw rehmannia, 12-18 parts of bupleurum, 8-12 parts of fried licorice, 12-18 parts of poria, 12-18 parts of cortex meliae, 12-18 parts of white atractylodes, 12-18 parts of white peony root.The present application has the core efficacy of clearing and draining liver and gallbladder dampness, enhances the efficacy of invigorating spleen, nourishing blood, softening liver and directly improving skin performance, thereby more safely and effectively improving liver and gallbladder dampness and spleen deficiency and blood weakness type skin yellow turbidity problem.

The invention provides a jaundice treatment device with uniform irradiation, and relates to the technical field of medical instruments. The mounting supporting part is fixedly connected with a supporting light-transmitting device; an irradiation device is rotationally connected to the supporting light-transmitting device. Four mobile detection parts are connected to the mounting supporting part in a sliding manner; two lifting pressing pieces are connected to the four mobile detection parts in a sliding manner; a lifting control piece is connected to the mounting supporting part in a sliding manner; the jaundice treatment device can assist in whole-body irradiation, can effectively guarantee the irradiation treatment effect, is better in irradiation distance control effect and safer, and solves the problems that an existing uniform-irradiation jaundice treatment device easily causes poor skin ventilation effect on the back of an infant, causes discomfort or skin diseases and the like, cannot assist in infant body position detection, and is not convenient to use. And safety accidents caused by undiscovered discomfort of the infant are easily caused.

The invention belongs to the technical field of medicines, and particularly relates to a Beijing pharmaceutical composition for preparing a medicine for repairing liver injury, which is extracted from the following raw materials in parts by weight: 17-20 parts of oriental wormwood, 8-12 parts of polyporus umbellatus, 3-4 parts of rhizoma atractylodis, 8-12 parts of akebiaquinata, 10-14 parts of radix bupleuri, 10-14 parts of poria cocos, 10-14 parts of semen plantaginis, 10-14 parts of cape jasmine and 4-6 parts of rhizoma alismatis. The composition disclosed by the invention can effectively relieve jaundice caused by damp-heat, relieve skin and hair yellow staining and digestive tract symptoms, promote abnormal excrement recovery, improve the inflammatory state of a body, protect liver tissues, reduce necrosis, degeneration and inflammatory infiltration of liver cells, relieve hepatic congestion, regulate liver function indexes and remarkably reduce ALT and AST levels of serum. The traditional Chinese medicine composition has the effects of eliminating dampness and heat and soothing the liver to relieve pain, and can be used for people with hepatic insufficiency, abdominal pain, jaundice, bitter and sticky mouth, whole body sleepiness, chest and hypochondrium swelling and stuffiness, red tongue, yellow / yellow and greasy tongue coating and the like.

A pediatric nursing jaundice irradiation device provided by the present invention comprises a jaundice irradiation assembly, the jaundice irradiation assembly comprises a box body, a relative rotation mechanism, a protection observation mechanism, a U-shaped mounting rack, a baby bed mechanism and a jaundice irradiation lamp, and the relative rotation mechanism is arranged on the box body; an output shaft of a first servo motor drives a rotating rod to rotate, and the rotating rod drives a base to reciprocate through a plurality of reciprocating units, so that an infant bed body on the base is in a reciprocating cradle state, and a neonate with pathological jaundice can quickly fall asleep in a treatment box; the base is in transmission through the relative rotating unit, the U-shaped mounting frame and the crib mechanism are made to do relative reciprocating motion, the U-shaped mounting frame drives the jaundice irradiation lamp to do reciprocating motion, and therefore the jaundice irradiation lamp can evenly irradiate the side face of a newborn with pathological jaundice, and the side face of the newborn with pathological jaundice is prevented from being damaged by the jaundice irradiation lamp. Therefore, the light irradiation treatment effect is improved.

This utility model belongs to the field of jaundice treatment technology and discloses a blue light blocking device for neonatal jaundice treatment, including: an adjustment mechanism, comprising a rotating component and a cover component. The rotating component includes a central circular block, and a movable collar is sleeved on the outer side of the central circular block. The movable collar is connected to the blue light blocking glass cover through a connecting block. Compared with the prior art, this utility model has the following beneficial effects: By designing the adjustment mechanism, the rotation of the rotating screw can drive the sliding block to slide up and down inside the guide groove. This allows the blue light blocking glass cover to descend smoothly, covering the treatment box to activate blue light treatment; or to rise smoothly before and after treatment, away from the treatment box, facilitating subsequent operations. When it is necessary to put the newborn into or take the newborn out of the treatment box, the blue light blocking glass cover can be pushed backward, allowing it to rotate above the treatment box without obstructing the view above the treatment box, making it easy to put the newborn into or take the newborn out of the treatment box and reducing the risk of injury to the newborn.

The invention discloses a composite liver and kidney protective agent as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The protective agent is prepared from 10%-20% of inosine, 15%-25% of glutamic acid, 10%-15% of cysteine, 15%-20% of glycine, 5%-10% of a coenzyme compound, 10%-20% of small molecule peptide and auxiliary materials. The preparation method comprises the steps of premixing, low-temperature homogenization, spray drying and preparation forming, and uniform distribution of components is ensured through a spray drying technology. The traditional Chinese medicine composition plays a role through a three-stage mechanism of fat removal, repair and regeneration, reduces lipid deposition, scavenges free radicals, repairs hepatocytes and promotes regeneration. The traditional Chinese medicine composition can be used for treating or preventing liver and kidney diseases such as non-alcoholic fatty liver, viral hepatitis and cirrhosis, relieving symptoms such as anorexia, jaundice and bleeding, dispelling the effects of alcohol, protecting the liver and enhancing immunity. The proportion of natural components of the protective agent is more than 80%, the safety is high, multiple targets are synergistic, and the curative effect is superior to that of a single-component medicine.

The utility model relates to the technical field of pediatric jaundice treatment equipment, in particular to a pediatric nursing bed with a jaundice irradiation function. According to the technical scheme, the device comprises a jaundice treatment bed and a jaundice irradiation mechanism arranged at the top of the jaundice treatment bed, a newborn and a feeding bottle for feeding the newborn are arranged in the jaundice irradiation mechanism, and the device further comprises a pair of second glass baffles arranged in the jaundice irradiation mechanism. And a fixing bottle clamp for supporting the feeding bottle is arranged in the jaundice irradiation mechanism. Through the cooperation of the second glass baffle, the fixed bottle clamp, the support mechanism and other structures, a feeding person does not need to stand, squat or bend down to feed milk, postpartum rest is very important for the feeding person, physical burdens are reduced, the feeding person can better recover the body, meanwhile, the actions are avoided, and the labor intensity of the feeding person is reduced. The pressure of the waist and the back can be relieved, and muscular soreness or lumbar vertebra problems caused by improper postures are reduced.